ARA American Renal Associates Holdings Inc.

American Renal Associates Holdings, Inc. Receives 2016 Press Ganey Guardian of Excellence Award for Outstanding Performance in Physician Engagement

American Renal Associates Holdings, Inc. today announced it has been named a 2016 Guardian of Excellence Award® winner by Press Ganey. The Guardian of Excellence Award recognizes top-performing health care organizations that have consistently achieved the 95th percentile or above of performance in Physician Engagement.

The Press Ganey Guardian of Excellence Award is a nationally-recognized symbol of achievement in health care. Presented annually, the award honors clients who consistently sustained performance in the top 5% of all Press Ganey clients for each reporting period during the course of one year.

In a recent Press Ganey survey, 99% of physicians surveyed stated they would recommend ARA to other physicians and medical staff as a good place to practice medicine, and 98% stated the clinic provides high quality care and service. Additionally, 96% of physicians surveyed reported they have adequate input into clinic decisions that impact how they practice medicine.

“We are honored to be recognized with Press Ganey’s Guardian of Excellence Award,” said Joseph (Joe) Carlucci, Chairman and CEO. “We strongly value the partnerships we have with leading nephrologists around the country, and I believe this award highlights how our business model can improve the patient experience through physician engagement. By giving our physician partners autonomy to make clinical and operational decisions, our partnership model fosters an environment of strong physician engagement and very high physician satisfaction.”

"We are proud to partner with American Renal Associates,” said Dr. Thomas H. Lee, Chief Medical Officer of Press Ganey. “This award is a testament to the organization’s leadership in delivering patient-centered care. By achieving and sustaining this level of excellence, American Renal Associates continues to demonstrate their commitment to reducing patient suffering and advancing the overall quality of health care.”

About American Renal Associates

American Renal Associates Holdings, Inc. (NYSE: ARA) is a leading provider of outpatient dialysis services in the United States. As of September 30, 2016, ARA operated 207 dialysis clinic locations in 25 states and the District of Columbia serving approximately 14,160 patients with end stage renal disease. ARA operates exclusively through a physician joint venture model, in which it partners with approximately 370 local nephrologists to develop, own and operate dialysis clinics. ARA’s Core Values emphasize taking good care of patients, providing physicians with clinical autonomy and operational support, hiring and retaining the best possible staff and providing best practices management services. For more information about American Renal Associates, visit www.americanrenal.com.

About Press Ganey

Press Ganey is a leading provider of patient experience measurement, performance analytics and strategic advisory solutions for health care organizations across the continuum of care. With over 30 years of experience, Press Ganey is recognized as a pioneer and thought leader in patient experience measurement and performance improvement solutions. Our mission is to help health care organizations reduce patient suffering and improve clinical quality, safety and the patient experience. As of January 1, 2016, Press Ganey served more than 26,000 health care facilities. For more information, visit www.pressganey.com.

EN
02/12/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on American Renal Associates Holdings Inc.

 PRESS RELEASE

American Renal Associates Holdings, Inc. Announces Third Quarter 2020 ...

BEVERLY, Mass.--(BUSINESS WIRE)-- American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced financial and operating results for the third quarter ended September 30, 2020. Certain metrics, including those expressed on an adjusted basis, are Non-GAAP financial measures (See “Use of Non-GAAP Financial Measures” and the reconciliation tables further below). Third Quarter 2020 Highlights (all percentage changes compare Q3 2020 to Q3 2019 unless noted): Patient service operati...

 PRESS RELEASE

American Renal Associates Enters Into Definitive Agreement to be Acqui...

BEVERLY, Mass.--(BUSINESS WIRE)-- American Renal Associates Holdings, Inc. (NYSE: ARA) (“ARA” or the “Company”), a leading provider of outpatient dialysis services, today announced that it has entered into a definitive agreement to be acquired by Innovative Renal Care, LLC (“IRC”), an affiliate of Nautic Partners, LLC (“Nautic”), a middle market private equity firm, in an all-cash transaction that values the Company at an aggregate enterprise valuation of approximately $853 million excluding non-controlling interest. Under the terms of the agreement, ARA shareholders will receive $11.50 per sh...

 PRESS RELEASE

American Renal Associates Holdings, Inc. Announces Settlement of Share...

BEVERLY, Mass.--(BUSINESS WIRE)-- American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading provider of outpatient dialysis services, is pleased to announce that the Company has received preliminary approval of the settlement of a stockholder derivative action brought by Plaintiff Luke Johnson, and pending in the United States District Court for the District of New Jersey (case number No. 19-cv-15812) (the “Johnson Action”). The proposed settlement releases all claims asserted against the Company and the other named defendants in the Johnson Action without any liability o...

 PRESS RELEASE

American Renal Associates Holdings, Inc. Announces Second Quarter 2020...

BEVERLY, Mass.--(BUSINESS WIRE)-- American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced financial and operating results for the second quarter ended June 30, 2020. The Company also provided an update on its COVID-19 impact and affirmed its 2020 Adjusted EBITDA less noncontrolling interests (“Adjusted EBITDA-NCI”) Outlook. These updates are highlighted later in this release. Certain metrics, including those expressed on an adjusted basis, are Non-GAAP financial measures ...

 PRESS RELEASE

American Renal Associates Holdings, Inc. Announces Second Quarter 2020...

BEVERLY, Mass.--(BUSINESS WIRE)-- American Renal Associates Holdings, Inc. (NYSE: ARA), a leading kidney care and dialysis services provider focused on partnering with local nephrologists, announced today that it will release its second quarter 2020 earnings results after the market close on Monday, August 10, 2020, to be followed by a conference call on Tuesday, August 11, 2020 at 9:00 a.m. (Eastern Time). The conference call can be accessed live over the phone by dialing (877) 407-8029, or for international callers (201) 689-8029. A replay will be available one hour after the call and can ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch